Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson major customer concentration — McKesson Corporation (% of revenue) (%)
Form 10-K Note 18 (Segments & Geographic Information)
Latest, FY2025
15.5%
Period ended Dec 28, 2025
Change on a year earlier
-0.1 pts
15.6% in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Major customer concentration — McKesson Corporation (% of revenue) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 15.5% | -0.1 pts | Form 10-K (filed 2026-02-11) ↗ |
| FY2024 | Dec 29, 2024 | 15.6% | +0.5 pts | Form 10-K (filed 2026-02-11) ↗ |
| FY2023 | Dec 31, 2023 | 15.1% | +0.1 pts | Form 10-K (filed 2026-02-11) ↗ |
| FY2022 | Jan 1, 2023 | 15.0% | +2.4 pts | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Jan 2, 2022 | 12.6% | +0.6 pts | Form 10-K (filed 2024-02-16) ↗ |
| FY2020 | Jan 3, 2021 | 12.0% | 0.0 pts | Form 10-K (filed 2023-02-16) ↗ |
| FY2019 | Dec 29, 2019 | 12.0% | +1.0 pts | Form 10-K (filed 2022-02-17) ↗ |
| FY2018 | Dec 30, 2018 | 11.0% | +1.0 pts | Form 10-K (filed 2021-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 10.0% | -0.7 pts | Form 10-K (filed 2019-02-20) ↗ |
| FY2016 | Jan 1, 2017 | 10.7% | – | Form 10-K (filed 2019-02-20) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Major customer concentration — McKesson Corporation (% of revenue) (%), annual FY2016–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/conc_wholesaler_2
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.